Researchers sought to determine whether long noncoding RNA expression would have prognostic significance for pediatric patients with AML.
Researchers sought to determine whether a higher frailty score would be linked with cost of care in patients with MDS.
Researchers sought to determine whether adding bortezomib to DRC would improve survival in patients with Waldenström macroglobulinemia.
Researchers sought to determine whether greater Vδ2-positive T-cell recovery would impact mortality for patients with AML who undergo haplo-HCT.
Researchers sought to determine the costs associated with SCD in the United States.
Researchers sought to determine whether reducing IV crystalloid fluid administration may decrease the risk of respiratory failure in patients receiving haplo-SCT.
Researchers evaluated whether patients who undergo allo-HCT who have a rapid and robust immune recovery have improved clinical outcomes, including OS rates.
Researchers evaluated immune and metabolic function from samples of patients in the ALLOZITHRO trial to determine how azithromycin increases relapse risk after ASCT.
Researchers sought to determine whether conversion of MRD status during maintenance would affect risk of disease progression in patients with MM.
Researchers sought to determine whether first-line brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine would yield favorable results in HL.
